Rockwell Medical, Inc. (RMTI)
| Market Cap | 33.13M-32.1% |
| Revenue (ttm) | 69.39M |
| Net Income | -5.24M |
| EPS | -1.34 |
| Shares Out | 4.03M |
| PE Ratio | n/a |
| Forward PE | 117.43 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 377 |
| Open | 7.68 |
| Previous Close | 8.22 |
| Day's Range | 7.68 - 8.31 |
| 52-Week Range | 4.89 - 12.90 |
| Beta | 1.63 |
| Analysts | none |
| Price Target | 20.00(+143.31%) |
| Earnings Date | Nov 11, 2026 |
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
About RMTI
Rockwell Medical, Inc., together with its subsidiaries, engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. It offers citrapure citric acid concentrate, dri-sate dry acid concentrate, renalpure liquid acid concentrate, dri-sate acid concentrate mixer, renalpure acid concentrate, renalpure bicarbonate concentrate, sterilyte bicarbonate concentrate, bicarbonate cartridges, and dry acid concentrate mixer, as well as ancillary products, including 5% acetic acid, cleaner, citric acid descaler, water softener salt pellets, and other supplies used by hemodialysis providers. The company's hemodialysis concentrate products are used to sustain patient's life by removing toxins and balancing electrolytes in a dialysis patient's bloodstream. In addition, it offers dialysis concentrates, dialysis kits, and other ancillary products used in the dialysis process. The company was formerly known as Rockwell Medical Technologies, Inc. and changed its name to Rockwell Medical, Inc. in June 2012. Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$RMTI stock is featured in our Insider Score Rankings, and Insider Trades datasets.
→ All Stock ListsRecently reported changes in RMTI holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by RMTI's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
RMTI Estimated quarterly lobbying spending
Source: U.S. Senate LDA
RMTI Revenue by Segment or Geography
| Segment | Revenue | % of All |
|---|---|---|
| Employee Compensation | $2.48M | 55.82% |
| Administrative Costs | $1.83M | 41.25% |
| Realized Gain on Available-for-Sale Investments | $130.00K | 2.93% |
As of: Q2 2026 (Jun 30, 2026) · Source: SEC EDGAR (10-Q)
U.S. Patents
New RMTI patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to RMTI from public contracts
Source: USAspending.gov
RMTI Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from RMTI’s recent data — informational, not investment advice
Insider Score
Our 0–100 Insider Score and the signals behind it.
The live Insider Score and its full factor breakdown are included with Insider Access.
Unlock Insider Score